We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » ITC to Investigate Amgen Complaint Over Roche’s Anemia Drug
ITC to Investigate Amgen Complaint Over Roche’s Anemia Drug
May 10, 2006
The U.S. International Trade Commission (ITC) plans to investigate Amgen’s claim that Roche’s importation of the anemia drug Cera violates Amgen’s patents on its anemia treatment Epogen, Amgen said May 9.